文献速递姑息放疗与转移瘤

单次与多次分割姑息放疗治疗骨转移的累积荟萃分析

Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis.
PubMed 文献 · Radiother Oncol · 2019-08-21

该累积荟萃分析纳入29项研究,评估单次分割放疗(SFRT)与多次分割放疗(MFRT)治疗骨转移的疗效随时间的变化。结果显示,除可评估患者的总体缓解率外,其余终点均维持相同荟萃结论,即SFRT与MFRT疗效相当;多数纳入研究偏倚风险低。作者认为现有证据已充分,未来资源不应重复此类随机试验。

要点

  • SFRT与MFRT治疗骨转移的疗效相当,累积荟萃结论随时间保持稳定。
  • 除可评估患者的总体缓解率外,其余终点均维持相同荟萃结论。
  • 多数纳入随机对照试验偏倚风险低,现有证据已足够支持该结论。

核心结论

  • 累积荟萃分析表明,SFRT与MFRT治疗骨转移的疗效相当,该荟萃结论随时间保持稳定。
  • 近期研究对总体结论影响甚微,未来资源不应重复此类随机试验,而应分配至其他假设的验证。

研究设计与样本

  • 累积荟萃分析,共纳入29项研究,使用Comprehensive Meta-Analysis(Version 3)进行累积分析。
  • 采用Cochrane偏倚风险评估工具评估纳入随机对照试验的研究质量,并使用Review Manager(RevMan 5.3)生成漏斗图以视觉评估发表偏倚。

主要发现

  • 除可评估患者的总体缓解率这一终点外,其余所有终点在发表时间轴上均维持相同的荟萃结论。
  • 已发表研究未改变现有文献的合并科学结论,额外研究仅确认了既有结论并细化了疗效估计的点估计值。
  • 多数纳入研究的偏倚风险低。

临床怎么用

  • 对于骨转移的姑息放疗,SFRT与MFRT疗效相当,临床可根据患者具体情况选择单次分割方案。
  • 现有累积荟萃证据已充分,无需再开展重复性随机对照试验来比较SFRT与MFRT。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There has been a long-standing debate regarding the efficacy of single fraction radiotherapy (SFRT) compared to multiple fraction radiotherapy (MFRT); many systematic reviews and meta-analyses have been conducted to resolve the debate and suggested SFRT is equally as effective as MFRT. Given the adequate amalgamated sample size that exists, it is difficult to appreciate the need for further RCTs. The aim of this paper was to conduct a cumulative meta-analysis to determine whether further trials will be of value to the meta-conclusion. This paper also assessed publication quality. METHODS: A total of 29 studies were used in our meta-analysis. Comprehensive Meta-Analysis (Version 3) by Biostat was used to conduct a cumulative meta-analysis. The Cochrane Risk of Bias assessment tool was employed to assess study quality of the included RCTs. Funnel plots were generated using Review Manager (RevMan 5.3) by Cochrane IMS, to visually assess for publication bias. RESULTS: All but one endpoint, overall response rates in assessable patients, maintained the same meta-conclusion over publication time; published studies did not change the amalgamated scientific conclusion of existing literature. Additional studies have simply confirmed pre-existing conclusions and refined the point estimate of the efficacy estimate. The majority of included studies have low risk of bias. CONCLUSION: In conclusion, the meta-conclusion has remained consistent over time - SFRT is equally as efficacious as MFRT. Recent studies have had little impact on the overall conclusion, and given the vast amount of resources to execute a randomized trial, future resources should not be used to repeat these studies, and can be better allocated to test other hypotheses.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Chow R, Hoskin P, Schild SE, et al. Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis. Radiother Oncol. 2019. PMID: 31445837. doi:10.1016/j.radonc.2019.06.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。